Co-Diagnostics advances Ebola PCR test development with CoSara venture

Go back to Co-Diagnostics advances Ebola PCR test development with CoSara venture
(NASDAQ: CODX) Delayed: 3.12 --0 (-0%)
Previous Close $3.12    52 Week High
Open $3.12    52 Week Low
Day High $3.12    P/E N/A 
Day Low $3.12    EPS
Volume 8,120